Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-07-01 Sale |
2022-07-06 5:01 pm |
MAXCYTE INC. | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner |
3,235,548 | $4.3 | $13,912,856 | 10,735,786 (Direct) |
View |
2021-08-03 Purchase |
2021-08-04 6:33 pm |
Tenaya Therapeutics Inc. | TNYA | Casdin Partners Master Fund L.P. Casdin Private Growth Equity Fund L.P. Casdin Capital LLC CASDIN PRIVATE GROWTH EQUITY FUND GP LLC 10% Owner |
850,000 | $15 | $12,750,000 | 361,969 (Indirect) |
View |
2021-07-30 Purchase |
2021-08-03 6:08 pm |
MAXCYTE INC. | MXCT | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner |
1,800,000 | $13 | $23,400,000 | 13,971,334 (Direct) |
View |
2021-07-26 Purchase |
2021-07-28 4:33 pm |
Absci Corp | ABSI | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Private Growth Equity Fund L.P. CASDIN PRIVATE GROWTH EQUITY FUND GP LLC Director |
1,562,500 | $16 | $25,000,000 | 7,718,593 (Indirect Direct) |
View |
2020-11-24 Purchase |
2020-11-27 5:23 pm |
BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner |
1,600,000 | $22.5 | $36,000,000 | 7,440,107 (Direct) |
View |
2020-07-01 Purchase |
2020-07-02 4:48 pm |
BIOLIFE SOLUTIONS INC | BLFS | Casdin Partners Master Fund L.P. Casdin Capital LLC Casdin Partners GP LLC Casdin Eli 10% Owner |
990,583 | $14.5 | $14,363,454 | 5,840,107 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion